article thumbnail

Jessica Ringena Named President of Amber Specialty Pharmacy

Amber

19, 2024) – Amber Specialty Pharmacy announces the appointment of Jessica Ringena as its newest president. Ringena previously served as president of Vivid Clear Rx, a pharmacy benefit manager and subsidiary of Hy-Vee. The provider specializes in transplant, infusion and specialty care, including rare/orphan drugs and oncology.

article thumbnail

Use Your Hospital’s Retail Pharmacy 340B Drug Savings To Build A Specialty Pharmacy

Proxsys Rx

For 340B-eligible hospitals dealing with increasingly tight bottom lines (which essentially means all 340B-eligible hospitals), an in-house specialty pharmacy offers enormous savings and revenue potential. What is a Specialty Pharmacy? That’s roughly six times faster than overall growth in the specialty drug market.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Specialty Pharmacy’s Explosive 340B Growth

Drug Channels

As you will see below, mail and specialty pharmacies’ purchases of products that are eligible for 340B discounts have grown by an incredible 56% per year since 2017. That’s about six times faster than the overall mail and specialty market. Consequently, specialty pharmacies have gained a greater share of the 340B market.

article thumbnail

Relief for Amylyx as FDA clears controversial ALS drug Relyvrio

pharmaphorum

The approval makes Relyvrio (sodium phenylbutyrate and taurursodiol) the first new therapy option for ALS – also known as motor neuron disease (MND) – since Mitsubishi Tanabe Pharma’s intravenous Radicava (edaravone) was cleared by the FDA in 2017. An oral version of edaravone was cleared this year.

article thumbnail

NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

Putting Patients First Blog

Pharmacy benefit managers: transparency, accountability, and impact on patient care. Journal of Managed Care & Specialty Pharmacy, 27(7), 903-907. Retrieved from https ://www.acc.org/latest-in- cardiology/articles/2017/02/21/12/42/barriers-to-new-medications-for-cardiovascular-disease-insights- from-cardiosurve?

article thumbnail

NHC Submits Comments to CMS RE CY 2026 Policy & Technical Changes to MA and Part D Proposed Rule

Putting Patients First Blog

Consequences of Obesity, last reviewed May 15, 2023, [link] www.cdc.gov/obesity/basics/consequences.html 6 Libbi Green and Patty Taddei-Allen, “Shifting Paradigms: Reframing Coverage of Antiobesity Medications for Plan Sponsors,” Journal of Managed Care & Specialty Pharmacy 29, no. 14 National Health Council.

article thumbnail

NHC Comments on Notice of Proposed Rulemaking on Discrimination on the Basis of Disability in Health and Human Service Programs or Activities

Putting Patients First Blog

According to a 2017 report by the National Council on Disability, individuals with disabilities often face significant barriers in accessing health care services, including discriminatory attitudes from health care.9 The NHC supports the core tenet of the proposed § 84.56(b)(1), 9 Proposed paragraph 84.56(b)(1)(i) Has the promise been kept?